Early Treatment May Prevent Blindness in ROP Patients

April 21st, 2010

A recent study reveals that early treatment of retinopathy of prematurity can provide affected infants with long-term benefits. The study, Early Treatment for Retinopathy of Prematurity (ETROP) was published in the Archives of Ophthalmology April 12, 2010.

Study authors say children with ROP should be examined to determine if they are at risk of complete retinal detachment. If high risk is determined, study authors say early treatment may benefit them for at least six years.

The study followed 370 children with retinopathy of prematurity to the age of 6 to determine if there were continued benefits of early treatment. According to the findings, 75 percent of the children who received early treatment did not become blind. This is compared to 67 percent of children who were treated at the standard time.

The findings refer to children with type 1 ROP. Type 1 is classified as more severe form of retinopathy of prematurity (or those with a higher risk of retinal detachment). Doctors are able to tell whether an infant has Type 1 or Type 2 ROP by conducting an eye exam. The study suggests that patients should be treated using different strategies based on the risk of the disease progressing to a more severe state, which may result in blindness.

(Source: Science Daily)

For more information about treatment options for premature newborns diagnosed with retinopathy of prematurity, contact our ROP lawyers today. We may be able to help you seek compensation.